Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 02, 2008. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically detailing changes in interests in Ordinary shares and American Depository Shares (ADSs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding director share allocations and does not contain financial performance data.
Material Changes
On December 31, 2007, the Company's Non-Executive Directors were provisionally allocated awards under share allocation arrangements for the service period from October 1, 2007, to December 31, 2007. The Company and the directors were informed of these allocations on January 2, 2008.
Director Share Allocations
| Non-Executive Director | Ordinary Shares | American Depository Shares (ADSs) |
|---|---|---|
| Sir Christopher Gent | 2,238.52 | - |
| Prof Sir Roy Anderson | 437.97 | - |
| Dr Stephanie Burns | 357.38 | - |
| Mr Lawrence Culp | 536.07 | - |
| Sir Crispin Davis | 1,167.92 | - |
| Sir Deryck Maughan | 714.76 | - |
| Dr Daniel Podolsky | 491.40 | - |
| Sir Ian Prosser | 875.94 | - |
| Dr Ronaldo Schmitz | 467.17 | - |
| Mr Tom de Swaan | 437.97 | - |
| Sir Robert Wilson | 389.31 | - |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to the Disclosure and Transparency Rule 3.1.4R(1)(a) regarding director transactions.
Investor Verification Points
- Verify the final vesting status of the provisional share allocations listed for Non-Executive Directors.
- Confirm the total number of Ordinary Shares and ADSs held by each director following this allocation.
- Review the specific terms of the share allocation arrangements for the period of October 1, 2007, to December 31, 2007.